title: Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
authors.affiliation: Columbia University Medical Center, New York, NY. gs2184@columbia.edu
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.affiliation: University Hospitals Cleveland Medical Center, Cleveland, OH
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Sabik
authors.affiliation: Imperial College London, London, United Kingdom
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
authors.affiliation: Erasmus Medical Center, Rotterdam, the Netherlands
authors.forename: A Pieter
authors.initials: AP
authors.lastname: Kappetein
mesh_terms: D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000188:drug therapy; D023903:Coronary Restenosis / Q000188:drug therapy; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D062645:Percutaneous Coronary Intervention; D020123:Sirolimus / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000068338:Everolimus; D020123:Sirolimus